Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Radiopharmaceutical Manufacturing (Tc99m, Lu177, Cu64 Series)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks a subcontractor to produce clinical-grade radiopharmaceuticals including Tc99m-labeled agents, Lu177 DOTATATE, and Cu64 Dotatate, with comprehensive quality control measures fully integrated into the manufacturing process. The work requires adherence to strict regulatory and safety standards to ensure the purity, potency, and sterility of each radiopharmaceutical batch intended for patient use. All production must be conducted in compliance with current good manufacturing practices and validated procedures to support clinical applications and regulatory submissions. The contract is administered by the Department of Veterans Affairs through the 261-NETWORK Contract Office 21, with performance required to take place in Reno, Nevada, at the specified zip code 89502. The solicitation was posted on July 27, 2026, and responses are due by August 3, 2026, at 6:00 PM Eastern Time. This is a subcontract opportunity under NAICS code 325412, which corresponds to pharmaceutical and medicine manufacturing, and while no set-aside designation is specified, potential bidders must be prepared to meet the technical, regulatory, and logistical demands of producing multiple radiopharmaceuticals under a tight timeline.

General Info

Produce clinical-grade radiopharmaceuticals in Reno, NV, under GMP for VA, with QC and regulatory compliance.

Agency

Department Of Veterans Affairs → 261-NETWORK Contract Office 21 (36C261)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Reno, NV, 89502, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 261-NETWORK Contract Office 21 (36C261)
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Veterans Affairs → 261-NETWORK Contract Office 21 (36C261)
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Production of clinical-grade radiopharmaceuticals including Tc99m-labeled agents, Lu177 DOTATATE, and Cu64 Dotatate with full quality control.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZINC OXIDE OINTMENT USP, containing 20% zinc oxide in a 1-ounce collapsible tube weighing 28.35 grams, is procured as a topical skin protectant under contract SPE2DP-26-T-4335. The item is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards per MIL-STD-129 and DLA Packaging Requirements for Procurement RP001. The product requires storage at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. All packaging must be marked in accordance with the latest Medical Marking Standard No. 1 and labeled with the NDC number 67777-0223-11. The unit of issue is the tube (TU), and no variance in quantity is permitted. The contract includes two line items totaling 14 tubes: 10 tubes delivered to a location in Richmond, Virginia, and 4 tubes delivered to Melrose, Massachusetts. Both deliveries are FOB destination with a five-day delivery window and must be shipped via traceable means—parcel post is prohibited. Packaging must adhere to ASTM D3951 if not classified as hazardous under FED-STD-313, but DLA requirements override any conflicting standards. Palletization follows RP001 guidelines, and all shipments must include proper government identification markings. The original required delivery dates are July 29, 2026, and July 30, 2026, respectively. The contract specifies a unit price of $1.00 per tube with no total price variation, and it is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with James McCullough as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ZOLMITRIPTAN TABLETZolmitriptan tablets, 2.5 mg film-coated, are supplied in blister packs containing six tablets per package, with the unit of issue defined as a package of six units. The product must be stored at controlled room temperature and marked in accordance with the latest edition of the Medical Marking Standard No. 1, adhering to DLA packaging requirements and technical quality standards as outlined in the DLA Master List of Technical and Quality Requirements. The item is classified as a Type I (Code Q) drug with a non-extendable shelf life of 36 months, and all supplies must comply with removal of government identification if not accepted, with potential application of Covered Defense Information protocols. The contract specifies two manufacturer part numbers—NDC71626-0101-06 from Medstone Pharma LLC and NDC60846-0130-30 from Amneal Pharmaceuticals of New York, LLC—both subject to FDA regulation and requiring prior confirmation via EBS referral by the contracting official. The delivery instruction requires FOB destination within 20 days, with no variance allowed in quantity, inspection and acceptance occurring at the delivery point, and packaging must meet MIL-STD-2073-1E standards. The contract, issued under solicitation SPE2DP-26-T-4332, has a posted date of July 28, 2026, and a response deadline of August 3, 2026, with three packages totaling 18 tablets ordered at $3.00 per package. The item is linked to NSN 6505015232352 and classified under NAICS code 325412 for pharmaceutical manufacturing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LACRINGER'S INJECTION, LACTATED, USP, 1000ML in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4338 with a total quantity of 3 cases, each containing 12 units, for delivery to Bogalusa, LA within five days under FOB destination terms. The product must be packaged in sealed unit containers that protect against damage and shipped in commercial exterior containers suitable for safe transport by common carrier at the lowest cost, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The item, manufactured by B. BROWN MEDICAL INC with NDC 00264-7750-00, has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C) with brief exposure up to 40°C permitted; freezing and excessive heat must be avoided. All packaging and labeling must adhere to the latest version of the Medical Marking Standard No. 1, available through DLA Troop Support, and technical and quality requirements referenced by R or I numbers are governed by the DLA Master List in effect at the solicitation or award date. The contract specifies zero variance in quantity, inspection and acceptance occur at delivery point, and government identification must be removed from non-accepted supplies. The FDA regulates this drug, requiring buyer referral via EBS to the product specialist, including manufacturer and bidder details. The purchase is under the DoD unit of issue system, and procurement falls under NAICS 325412.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTIONThe contract specifies the procurement of 2 bottles of Emollient Lotion, each containing 240 mL (8 FL OZ), packaged in a non-sterile bottle with a dispenser cap. The lotion must be an oil-in-water or water-in-oil emulsion containing a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional compliant ingredients such as stabilizers, thickening agents, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. It must maintain a pH between 5.0 and 8.1 and exhibit a viscosity of 10,000 to 20,000 CPS at 25°C when measured with a Brookfield Viscometer Model LVT using Spindle No. 13 at 6 RPM. The product is regulated by the FDA and must be stored at controlled room temperature. Packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 unless superseded by stricter DLA requirements. The unit of issue is a bottle (BT), and delivery is required FOB destination within 20 days of contract award to a military installation at Fort Bliss, Texas. No quantity variance is permitted, and inspection and acceptance occur at the destination. Traceable shipping methods are mandatory, and parcel post is prohibited. The contract reference number is SPE2DP-26-T-4329, with a required delivery date of July 29, 2026, and the product is identified by NSN 6508-01-019-7181. The supplier must meet all technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTIONDextrose Injection 5% USP is a sterile, nonpyrogenic, intravenous solution supplied in 1000 mL single-dose plastic bags, each containing 50 grams of anhydrous dextrose USP and water for injection USP. The product is latex-free and intended solely for intravenous administration. It is packaged in units of 12 bags per package, with a non-extendable shelf life of 30 months and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat. Packaging and marking must comply with the latest edition of the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with government identification removed from non-accepted supplies. The item is classified as a TYPE I (CODE P) product under DLA’s technical and quality requirements, which are governed by the DLA Master List referenced in the solicitation. The contract specifies a delivery requirement of five days FOB destination, with zero variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The supply is identified by NSN 6505013306252 and NDC codes corresponding to manufacturers ICU Medical, Inc. and B. Braun Medical Inc. The solicitation number is SPE2DP-26-T-4336, issued by the Department of Defense through the Medical Supply Chain Pharma FSA, with bids due by August 3, 2026, and a total contracted quantity of two packages, amounting to 24 bags.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles designated as Unit of Issue BT, with a total shelf life of 36 months and a minimum of 31 months remaining at the time of delivery to the first government activity. The product must be stored at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F–86°F). It is regulated by the FDA and classified as a hazardous material under Federal Standard No. 313-E, requiring compliance with OSHA’s updated Hazard Communication Standard, including submission of Safety Data Sheets and GHS-compliant labels prior to award. All packaging and marking must conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and adhere to DLA Packaging Requirements for Procurement, including palletization and commercial packaging per ASTM D3951 unless overridden by applicable DLA technical requirements. The item is supplied by Cardinal Health 200, LLC and Purdue Pharma LP under NDC 67618-0151-01. The contract requires six deliveries totaling 13 BT (bottles) to various U.S. Navy vessels and support units, with delivery scheduled within 30 days after award date. Each shipment is addressed to specific FPO locations and must be transported by traceable means via VSM; parcel post is prohibited. Pricing is firm fixed with zero variance tolerance, inspection and acceptance occur at destination, and FOB terms are destination. The solicitation, SPE2DP-26-Q-0122, incorporates mandatory technical and quality requirements from the DLA Master List, and includes federal clauses on veteran employment reporting, sustainable products, and wide area workflow payment. Delivery deadlines for individual line items range from May to June 2026, with all shipments subject to strict compliance with government-specific logistics and regulatory standards.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, UTolnaftate Powder USP 1% in 45 gram units is being procured under solicitation SPE2DP-26-T-4337 by the Department of Defense through the Medical Supply Chain Pharmaceutical FSA, with delivery required to Pearl Harbor, Hawaii. The contract specifies two quantities: two units and twenty units, each unit defined as one 45 gram container, with a total order value based on fixed unit pricing and no variance allowed in quantity. The material must be packaged in commercial containers that protect against damage and meet the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must comply with DLA Packaging Requirements for Procurement. The product has a non-extendable shelf life of 36 months and is not classified as hazardous under FED-STD-313, so it must be packaged per ASTM D3951, though all DLA Master List technical and quality requirements take precedence over commercial standards. Shipments must be traceable and cannot use parcel post; delivery is FOB destination with inspection and acceptance occurring at the final delivery point. The required delivery window is 20 days from the contract’s award, with an original delivery deadline of July 30, 2026. The supplier is Geri-Care Pharmaceuticals Corp. with NDC code 57896-0199-45 and the product is identified by NSN 6505-01-480-7897, while all packaging and labeling must conform to DLA’s current medical and logistics directives.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
BUTORPHANOL TARTRATE IButorphanol Tartrate Injection, Veterinary, is a Schedule IV controlled substance containing 10 mg of butorphanol per milliliter, approved for pain relief associated with colic in adult horses and yearlings. The product is supplied in 50 mL vials, with a total contract quantity of eight vials, and must be stored at controlled room temperature between 20–25°C (68–77°F) in a secured location due to its controlled substance classification. Once first punctured, the contents must be used within four months, and the item carries a non-extendable shelf life of 24 months under the Type I (Code M) requirement. The packaging and marking must comply with the latest Medical Marking Standard No. 1 and MIL-STD-2073-1E, and all government identification must be removed from non-accepted supplies per RQ011. The item is regulated by the FDA, and buyers are required to submit a referral via EBS with full manufacturer and product details for confirmation prior to award. The contract is issued under solicitation SPE2DP-26-T-4341 with delivery due in 89 days FOB destination, and no quantity variance is permitted. Approved manufacturers include Zoetis Inc., Patterson Veterinary Supply, and Covetrus North America, LLC, each with specified part numbers and NDC codes. The procurement is managed by the Department of Defense through the Medical Supply Chain Pharm FSA, with Shairy M. Cartagena as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPovidone-Iodine Cleansing Solution, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles under the unit of issue BT, with each BT representing three units. The product has a non-extendable shelf life of 36 months, and at least 31 months must remain upon delivery to the first government activity. Storage requirements specify 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The solution is regulated by the FDA and classified as a hazardous material under Fed-Std-313, requiring compliance with OSHA’s revised Hazard Communication Standard, including submission of Safety Data Sheets and GHS-compliant labeling prior to award. All packaging and labeling must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements. The material must be shipped via traceable means only, with parcel post strictly prohibited. Deliveries are required within 30 days after award, with firm fixed pricing and zero variance allowed. Six separate shipments are specified to different military vessels and facilities across the U.S., each with unique delivery addresses,RDD codes, and projected receipt dates ranging from June to July 2026. The contract incorporates all applicable DLA Master List of Technical and Quality Requirements, which override ASTM D3951 where applicable, and includes mandatory clauses on veteran employment reporting and sustainable product sourcing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPovidone-Iodine Cleansing Solution, USP, with 7.5% active ingredient, is procured for external use only in 1-gallon bottles identified by unit of issue BT, with a total shelf life of 36 months, requiring at least 31 months of remaining shelf life upon delivery to the first government activity. Storage must be maintained at 25°C (77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The product is regulated by the FDA and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards under RP001 and labeling requirements consistent with MIL-STD-129 and Medical Marking Standard No. 1, which supersedes MIL-STD-129. All packaging must ensure protection from damage and safe transportation via commercial carrier at the lowest rate, and palletization must adhere to DLA requirements. The material is classified as hazardous under Fed-Std-313, necessitating Safety Data Sheets (SDS) formatted to OSHA’s Hazard Communication Standard and compliant labels per 29 C.F.R. 1910.1200, with supplier employee training mandatory. Shipping instructions vary by destination but mandate use of traceable transport methods; parcel post is strictly prohibited. Deliveries are scheduled for FPO addresses aboard U.S. Navy vessels, with six separate line items totaling 22 BT (10, 4, 2, 1, 1, and 4 gallons) required under firm fixed pricing, no quantity variance allowed, inspection and acceptance occurring at destination. Delivery must occur within 30 days after award date, with specific shipping dates ranging from March to May 2026. The solicitation number is SPE2DP-26-Q-0121, issued by the Department of Defense Medical Supply Chain, and incorporates clauses related to veteran employment reporting, sustainable products, and wide area workflow payment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 11 hours ago

DEADLINE

in 8 days
View Details
NAICS: 325412
New
DIBBS
CIPROFLOXACIN TABLETSCiprofloxacin tablets, 500 mg unit dose in packages of 100, are being procured under solicitation SPE2DP-26-T-4316 with the NSN 6505012738650, requiring a total of three units of issue, each representing 100 tablets. The item must comply with all technical and quality standards listed in the DLA Master List of Technical and Quality Requirements, including specific packaging guidelines that mandate commercial packaging consistent with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a container that protects against damage, and all shipments must be packed in commercial exterior containers suitable for safe delivery via common carrier at the lowest cost to the specified destination. The product has a non-extendable shelf life of 36 months and must bear labels and markings in full compliance with medical marking standards. The supplier, The Harvard Drug Group, L.L.C., must deliver the item FOB destination within 20 days of contract award, with no variance allowed in quantity. Inspection and acceptance occur at the delivery point, and all materials must be prepared in accordance with MIL-STD-2073-1E. The contract includes applicable defense information controls, and government identification must be removed from any non-accepted supplies. The solicitation opened on July 27, 2026, with a response deadline of August 3, 2026, and is being managed by the Department of Defense’s Medical Supply Chain PHARM FSA with direct contact through James Foggie.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MECLIZINE HYDROCHLORIDMeclizine Hydrochloride Tablets USP, containing 25 milligrams of the active ingredient per tablet, are procured in bottles of 1,000 tablets, with a total shelf life of 24 months and a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) as per USP standards. Packaging must comply with commercial standards and meet the Medical Marking Standard No. 1, superseding MIL-STD-129, with all containers designed to prevent damage and ensure safe transport via common carrier at the lowest cost to the destination. The item is regulated by the FDA and requires referral to a product specialist for confirmation prior to award. The contract specifies delivery to Fort Bragg, North Carolina, within 20 days, with no variance allowed in quantity. The unit of issue is a bottle (BT), and palletization must follow DLA packaging requirements. The drug is supplied by approved manufacturers including Amneal Pharmaceuticals and Jubilant Cadista, with NDC identifiers provided. The material is not classified as hazardous per Fed-Std-313 and must be commercially packaged in accordance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence. Shipments must be traceable and不得 use parcel post. The solicitation number is SPE2DP-26-T-4296, with a response deadline of August 3, 2026, and the required delivery date is July 28, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Veterans Affairs → 261-NETWORK Contract Office 21 (36C261)

Same awarding agency

NAICS: 333993
New
Federal
Mobile Robot Stretch Wrap MachineThe U.S. Department of Veterans Affairs, through the 261-NETWORK Contract Office 21, is conducting market research to identify capable vendors who can provide two mobile robotic stretch wrap machines suitable for industrial warehouse use. The requirement is for machines that autonomously travel around stationary pallets to wrap oversized, irregular, and standard loads with a maximum wrap height of 84 inches and compatibility with 20-inch-wide stretch film rolls. The equipment must be robust, mobile, and designed for frequent, repetitive operation in a typical warehouse environment, with performance equivalent to or better than the Global Industrial Mobile Robot Stretch Wrap Machine. The North American Industry Classification System code for this requirement is 333993, which classifies packaging machinery manufacturing, and the small business size standard is 600 employees or fewer. Vendors are invited to submit information on their products’ technical capabilities, warranty and maintenance support, delivery timelines, and business size classification including any socio-economic designations such as 8(a), HUBZone, SDVOSB, or WOSB. This sources sought notice is not a solicitation and does not obligate the government to award a contract; it is intended solely for acquisition planning and market analysis. Responses are due by August 3, 2026, and should be directed to Jason Olliff at the provided contact information. The intended place of performance is North Las Vegas, Nevada, with the contracting office located in Mather, California. The government will use the vendor responses to refine its requirements, evaluate industry capabilities, and determine the most effective small business acquisition strategy for any future solicitation. No formal contract clauses or procurement documents are included in this notice, and any subsequent RFP, RFQ, or IFB will contain the full terms and conditions.
Packaging Machinery Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 6 days
View Details
NAICS: 541611
New
Federal
Software Supply Chain Integrity & Anti-Tampering ComplianceThis contract mandates strict adherence to software supply chain integrity and anti-tampering standards to ensure the authenticity and provenance of all delivered products. It requires the implementation of tamper-evident packaging and comprehensive chain-of-custody documentation to prevent unauthorized access, modification, or counterfeiting throughout the lifecycle of the software and related components. Compliance with ICTS supply chain restrictions is mandatory, specifically prohibiting the inclusion of materials or services from foreign adversaries as defined by U.S. federal guidelines. All parties must maintain verifiable records to demonstrate continuous security and control from origin through final delivery. The contract is classified as a subcontract under NAICS code 541611 and is administered by the Department of Veterans Affairs through the 261-NETWORK Contract Office 21. The response deadline is August 6, 2026, and the solicitation was posted on July 27, 2026. Performance is subject to federal cybersecurity and supply chain security protocols, with no flexibility allowed for non-compliant vendors. There is no set-aside designation, meaning eligibility is open to all qualified subcontractors who can meet the stringent anti-counterfeit and provenance requirements. All deliverables must align with the highest standards of digital integrity to protect federal systems and sensitive data from compromise.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 541512
New
Federal
Cybersecurity & Cryptographic Maintenance SupportThe contract requires support for maintaining TruDi system compliance with federal cryptographic standards, focusing on remote key establishment, emergency re-keying procedures, security patching, and ongoing maintenance of FIPS 140-2 validated cryptographic modules. These activities are critical to ensuring the integrity, confidentiality, and authenticity of sensitive data processed by the system, particularly in high-security operational environments where cryptographic protocols must remain up to date and fully compliant with federal mandates. The provider must deliver these services remotely and be prepared to respond immediately to security incidents requiring urgent cryptographic key renewal or system patching. This subcontract is issued under the NAICS code 541512 for Computer Systems Design Services by the Department of Veterans Affairs through the 261-NETWORK Contract Office 21. The solicitation was posted on July 27, 2026, with a response deadline of August 6, 2026. There is no specified set-aside classification or point of contact details provided, and the place of performance is not defined geographically, suggesting that all work will be performed remotely. The contract underscores the need for proven expertise in federal cybersecurity standards and the ability to support secure, continuous operations without physical access to the system infrastructure.
Computer Systems Design Services

POSTED

1 day ago

DEADLINE

in 9 days
View Details